Hepatic artery thrombosis
Conditions
Interventions
Low molecular weight heparin anticoagulant group:Anticoagulation with low molecular weight heparin within 14 days after orthotopic liver transplantation
Non-low molecular weight heparin anticoagulant group:No anticoagulation or low molecular heparin anticoagulation within 14 days after orthotopic liver transplantation
Sponsors
Department of Critical Care Medicine, Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients who received orthotopic liver transplantation at Renji Hospital affiliated to Medical College of Shanghai Jiaotong University from January 1, 2020 to November 30, 2020.
Exclusion criteria
Exclusion criteria: 1. Subjects younger than 18 years old; 2. Subjects who were lost to follow-up and had incomplete information during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Coagulation factor activity;Whole blood cell analysis;Platelet aggregation function;Thromboelastogram;Antithrombin III;Protein C Protein S;Liver and kidney function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hepatic artery width and blood flow velocity;Portal vein width and blood flow velocity; | — |
Countries
China
Contacts
Public ContactYuxiao Deng
Medical College of Shanghai Jiaotong University
Outcome results
None listed